Utama › Glioma › Washington › Seattle
Kajian klinikal Glioma di Seattle, WA
11 kajian untuk Glioma sedang mencari peserta di lokasi dalam dan sekitar Seattle (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) Glioma and High-Grade Glioma (HGG)
Mengambil pesertaFasa 1/2
- Seattle Children's Hospital, Seattle
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Mengambil pesertaFasa 2
- Seattle Children's Hospital, Seattle
Targeted Pediatric High-Grade Glioma Therapy
Mengambil pesertaKajian pemerhatian
- Seattle Children's Hospital, Seattle
Study of Olutasidenib and Temozolomide in HGG
Mengambil pesertaFasa 2
- Seattle Children's Hospital, Seattle
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
Mengambil pesertaFasa 3
- Fred Hutch Cancer Center, Seattle
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Mengambil pesertaFasa 2
- Seattle Children's Hospital, Seattle
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Mengambil pesertaFasa 2
- University of Washington School of Medicine, Seattle
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
Mengambil pesertaFasa awal 1Sukarelawan sihat dialu-alukan
- Seattle Children's Hospital, Seattle
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
Mengambil pesertaFasa 2
- Seattle Children's Hospital, Seattle
Study of B7-H3-Specific CAR T Cell Locoregional Immunotherapy for Diffuse Intrinsic Pontine Glioma/Diffuse Midline Glioma and Recurrent or Refractory Pediatric Central Nervous System Tumors
Mengambil pesertaFasa 1
- Seattle Children's Hospital, Seattle
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
Mengambil pesertaFasa awal 1
- Seattle Children's Hospital, Seattle
Kajian Glioma di bandar lain
- New York City, NY25 kajian
- Houston, TX23 kajian
- Boston, MA20 kajian
- Washington, DC19 kajian
- Philadelphia, PA16 kajian
- Miami, FL15 kajian
- Columbus, OH15 kajian
- San Francisco, CA14 kajian
- Chicago, IL13 kajian
- Durham, NC12 kajian
- Los Angeles, CA10 kajian
- St. Louis, MO10 kajian
Kajian lain di Seattle
- Kanser Paru-paru Bukan Sel Kecil53 kajian
- Kanser (semua jenis)49 kajian
- Kanser Prostat42 kajian
- Leukemia Mieloid Akut40 kajian
- Kanser Payudara39 kajian
- Kanser Metastatik39 kajian
- Kanser Kolorektal34 kajian
- Kanser Paru-paru33 kajian
- Kanser Ovari30 kajian
- Mieloma Pelbagai22 kajian
- Sindrom Mielodisplastik21 kajian
- Leukemia Limfoblastik Akut21 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.